CVE-2026-78407

Modified Modified - Updated After Analysis

Cross-Site Scripting in IBM Security Verify Access

Publication date: 2026-10-08

Last updated on: 2026-10-09

Assigner: IBM Corporation

Description

IBM Security Verify Access 10.0 through 10.0.9.2 and IBM Verify Identity Access 11.0 through 11.0.3 are vulnerable to cross-site scripting. This vulnerability allows an authenticated user to embed arbitrary JavaScript code in the Web UI thus altering the intended functionality potentially leading to credentials disclosure within a trusted session.

CVSS Scores

EPSS Scores

Probability:
Percentile:

Meta Information

Published

2026-10-08

Last Modified

2026-10-09

Generated

2026-10-19

AI Q&A

2026-10-09

EPSS Evaluated

2026-10-18

NVD

CVE-2026-78407

Affected Vendors & Products

Vendor	Product	Version / Range
ibm	verify_identity_access_container	From 11.0.0.0 (inc) to 11.0.3.0 (inc)
ibm	security_verify_access_container	From 10.0.0.0 (inc) to 10.0.9.2 (inc)
ibm	security_verify_access	From 10.0.0 (inc) to 10.0.9.3 (exc)
ibm	verify_identity_access	From 11.0 (inc) to 11.0.3.1 (exc)

Helpful Resources

Exploitability

CWE

KEV

CWE ID	Description
CWE-79	The product does not neutralize or incorrectly neutralizes user-controllable input before it is placed in output that is used as a web page that is served to other users.

Attack-Flow Graph

Executive Summary

This vulnerability is a cross-site scripting (XSS) flaw in IBM Security Verify Access 10.0 through 10.0.9.2 and IBM Verify Identity Access 11.0 through 11.0.3. An authenticated user can inject malicious JavaScript into the Web UI, which could alter functionality and potentially lead to credential disclosure during a trusted session.

Detection Guidance

This vulnerability involves cross-site scripting in IBM Security Verify Access and IBM Verify Identity Access. Detection requires checking for unauthorized JavaScript execution in the Web UI. No specific commands are provided in the context, but you should inspect web application logs for suspicious JavaScript injections and review user interface customizations for unapproved scripts.

Impact Analysis

If exploited, this vulnerability could allow attackers to steal user credentials or session tokens, leading to unauthorized access to sensitive data. It may also enable attackers to perform actions on behalf of legitimate users within the application.

Compliance Impact

This vulnerability could lead to data breaches, violating GDPR's data protection requirements and HIPAA's safeguards for protected health information. Organizations may face fines, legal penalties, and reputational damage due to non-compliance.

Mitigation Strategies

Apply the latest security patches or updates provided by IBM for IBM Security Verify Access 10.0 through 10.0.9.2 and IBM Verify Identity Access 11.0 through 11.0.3 to address the cross-site scripting vulnerability.

Hi! I’m here to help you understand CVE-2026-78407. Ask me anything about the vulnerability, its impact, or mitigation strategies.

0/70